Equity · Healthcare
HCA
NYSEHCA Healthcare (HCA)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for HCA to draw a line in its place.
- Market cap
- 98.9B USD
- P/E (TTM)
- 15.7
- Revenue, year to Dec 2025
- 75.6B USD
- EPS, diluted, year to Dec 2025
- 28.33 USD
- 52-week range
- 361.27 USD – 545.11 USD
- Avg volume
- 76.7K
as of Oct 30, 2026
Have HCA Healthcare (HCA) insiders bought or sold shares recently?
HCA has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 26 August 2026.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Feb 2026 | McAlevey Michael REVP & Chief Legal & Admin Off. | Sell | 1,694 | 904K USD |
| 11 Feb 2026 | Wyatt Christopher F.SVP & Controller | Sell | 4,000 | 2.0M USD |
| 11 Feb 2026 | Berres JenniferSVP & Chief Human Res. Officer | Sell | 8,020 | 4.1M USD |
| 03 Feb 2026 | HAZEN SAMUEL NCEO | Sell | 42,877 | 21.5M USD |
| 03 Feb 2026 | Cuffe Michael S.EVP and Chief Clinical Officer | Sell | 1,500 | 747K USD |
| 05 Nov 2025 | McAlevey Michael REVP & Chief Legal & Admin Off. | Sell | 3,892 | 1.8M USD |
| Sold | 6 open-market sales | 61,983 | $31.12M |
49 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 26 Aug 2026 | McAlevey Michael REVP & Chief Legal & Admin Off. | Other | 7,769 | 3.3M USD |
| 07 May 2026 | Marks Mike AEVP and CFO | Gift | 6,672 | |
| 28 Apr 2026 | FRIST THOMAS F IIIDirector | Award | 1,041 | |
| 28 Apr 2026 | Frist William RDirector | Award | 809 | |
| 28 Apr 2026 | Smith Andrea BDirector | Award | 509 | |
| 28 Apr 2026 | Riley Wayne JosephDirector | Award | 509 | |
| 28 Apr 2026 | MICHELSON MICHAEL WDirector | Award | 925 | |
| 28 Apr 2026 | Johnston Hugh FDirector | Award | 809 | |
| 28 Apr 2026 | DEPARLE NANCY ANNDirector | Award | 509 | |
| 28 Apr 2026 | CHIDSEY JOHNDirector | Award | 809 | |
| 13 Feb 2026 | McAlevey Michael REVP & Chief Legal & Admin Off. | Option exercise | 5,000 | 1.2M USD |
| 13 Feb 2026 | McAlevey Michael REVP & Chief Legal & Admin Off. | Tax withheld | 3,306 | 1.8M USD |
Showing the 12 most recent of 49 compensation filings in this window. The figures above count all of them.
Which funds hold HCA Healthcare (HCA)?
11 of the 45 institutional funds we track reported a HCA Healthcare position for the quarter ended 30 Jun 2026 — a combined 403.2M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Trimmed | 225,249 | 87.6M USD | −31.9% |
| Bridgewater Associates | Held (±25%) | 203,204 | 79.2M USD | +16.9% |
| Citadel Advisors | Trimmed | 184,460 | 71.9M USD | −28.7% |
| D. E. Shaw & Co. | Added | 139,447 | 54.4M USD | +179.3% |
| Marshall Wace | Added | 105,866 | 41.3M USD | +140.3% |
| Millennium Management | Added | 63,927 | 24.9M USD | +373.0% |
| Man Group | Held (±25%) | 60,069 | 23.4M USD | +15.3% |
| GAMCO Investors | Held (±25%) | 27,365 | 10.7M USD | −2.2% |
| Renaissance Technologies | New position | 18,600 | 7.3M USD | |
| Balyasny Asset Management | Added | 3,523 | 1.4M USD | +40.5% |
Showing the 10 largest of 11 reported positions. The figures above count all of them.
Have members of Congress traded HCA Healthcare (HCA)?
The most recent congressional trade disclosed in HCA Healthcare is a purchase by Jared Moskowitz (house, FL), dated 17 Jun 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 17 Jun 2026 | Jared Moskowitzhouse · Democrat–FL | Purchase | 1K USD–15K USD | 39 days |
| 11 Sep 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 41 days |
| 19 Aug 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 24 days |
| 15 May 2025 | Jared Moskowitzhouse · Democrat–FL | Purchase | 1K USD–15K USD | 43 days |
| 07 Apr 2025 | Julie Johnsonhouse · Democrat–TX | Sale | 1K USD–15K USD | 37 days |
| 25 Feb 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Sale | 1K USD–15K USD | 30 days |
| 27 Dec 2024 | Val T. Hoylehouse · Democrat–OR | Sale | 1K USD–15K USD | 259 days |
| 29 Oct 2024 | Val T. Hoylehouse · Democrat–OR | Purchase | 1K USD–15K USD | 318 days |
What has been filed or recorded for HCA Healthcare (HCA)?
The filings we hold for HCA Healthcare, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 7.27 USD | Revenue $19.85B |
| 30 Sep 2026 | Financials | Total assets | 63.5B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | −8.1B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 7.62 USD | Revenue $20.23B |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 7.15 USD | Revenue $19.11B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 28.33 USD | Revenue $75.60B |
| 31 Dec 2025 | Financials | Revenue | 75.6B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 6.8B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 28.33 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 6.96 USD | Revenue $19.16B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 6.83 USD | Revenue $18.61B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 6.45 USD | Revenue $18.32B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 22.00 USD | Revenue $70.60B |
HCA Healthcare (HCA): frequently asked questions
What is HCA Healthcare’s market cap?
HCA Healthcare is worth 98.9B USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is HCA Healthcare’s P/E ratio?
HCA Healthcare has a price-to-earnings ratio of 15.7, as of 30 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is HCA Healthcare’s revenue?
HCA Healthcare reported revenue of 75.6B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have HCA Healthcare insiders bought or sold shares recently?
No HCA Healthcare insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 26 Aug 2026 (SEC Form 4). See Insiders
Which funds own HCA Healthcare?
11 of the 45 funds we track reported a HCA Healthcare position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Bridgewater Associates and Citadel Advisors. See Funds
Have members of Congress traded HCA Healthcare?
Yes. 20 trades in HCA Healthcare appear in the congressional disclosures we hold; the latest is a purchase by Jared Moskowitz (House, FL) dated 17 Jun 2026, filed 26 Jul 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did HCA Healthcare last report earnings?
HCA Healthcare last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 7.27 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings